TY - JOUR A1 - Chakraborty, Sudipta A1 - Chen, Pan A1 - Bornhorst, Julia A1 - Schwerdtle, Tanja A1 - Schumacher, Fabian A1 - Kleuser, Burkhard A1 - Bowman, Aaron B. A1 - Aschner, Michael A. T1 - Loss of pdr-1/parkin influences Mn homeostasis through altered ferroportin expression in C-elegans JF - Metallomics : integrated biometal science Y1 - 2015 U6 - https://doi.org/10.1039/c5mt00052a SN - 1756-5901 SN - 1756-591X VL - 7 IS - 5 SP - 847 EP - 856 PB - Royal Society of Chemistry CY - Cambridge ER - TY - JOUR A1 - Chen, Pan A1 - DeWitt, Margaret R. A1 - Bornhorst, Julia A1 - Soares, Felix A. A1 - Mukhopadhyay, Somshuvra A1 - Bowman, Aaron B. A1 - Aschner, Michael A. T1 - Age- and manganese-dependent modulation of dopaminergic phenotypes in a JF - Metallomics : integrated biometal science Y1 - 2015 U6 - https://doi.org/10.1039/c4mt00292j SN - 1756-5901 SN - 1756-591X VL - 7 IS - 2 SP - 289 EP - 298 PB - Royal Society of Chemistry CY - Cambridge ER - TY - JOUR A1 - Schumacher, Fabian A1 - Chakraborty, Sudipta A1 - Kleuser, Burkhard A1 - Gulbins, Erich A1 - Schwerdtle, Tanja A1 - Aschner, Michael A. A1 - Bornhorst, Julia T1 - Highly sensitive isotope-dilution liquid-chromatography-electrospray ionization-tandem-mass spectrometry approach to study the drug-mediated modulation of dopamine and serotonin levels in Caenorhabditis elegans JF - Talanta : the international journal of pure and applied analytical chemistry N2 - Dopamine (DA) and serotonin (SRT) are monoamine neurotransmitters that play a key role in regulating the central and peripheral nervous system. Their impaired metabolism has been implicated in several neurological disorders, such as Parkinson's disease and depression. Consequently, it is imperative to monitor changes in levels of these low-abundant neurotransmitters and their role in mediating disease. For the first time, a rapid, specific and sensitive isotope-dilution liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated for the quantification of DA and SRT in the nematode Caenorhabditis elegans (C. elegans). This model organism offers a unique approach for studying the effect of various drugs and environmental conditions on neurotransmitter levels, given by the conserved DA and SRT biology, including synaptic release, trafficking and formation. We introduce a novel sample preparation protocol incorporating the usage of sodium thiosulfate in perchloric acid as extraction medium that assures high recovery of the relatively unstable neurotransmitters monitored. Moreover, the use of both deuterated internal standards and the multiple reaction monitoring (MRM) technique allows for unequivocal quantification. Thereby, to the best of our knowledge, we achieve a detection sensitivity that clearly exceeds those of published DA and SRT quantification methods in various matrices. We are the first to show that exposure of C elegans to the monoamine oxidase B (MAOB) inhibitor selegiline or the catechol-O-methyltransferase (COMT) inhibitor tolcapone, in order to block DA and SRT degradation, resulted in accumulation of the respective neurotransmitter. Assessment of a behavioral output of the dopaminergic system (basal slowing response) corroborated the analytical LC-MS/MS data. Thus, utilization of the C elegans model system in conjunction with our analytical method is well-suited to investigate drug-mediated modulation of the DA and SRT system in order to identify compounds with neuroprotective or regenerative properties. (C) 2015 Elsevier B.V. All rights reserved. KW - Caenorhabditis elegans KW - Dopamine KW - Serotonin KW - Liquid chromatography-tandem mass spectrometry KW - Isotope-dilution analysis Y1 - 2015 U6 - https://doi.org/10.1016/j.talanta.2015.05.057 SN - 0039-9140 SN - 1873-3573 VL - 144 SP - 71 EP - 79 PB - Elsevier CY - Amsterdam ER - TY - JOUR A1 - Kumar, Kevin K. A1 - Goodwin, Cody R. A1 - Uhouse, Michael A. A1 - Bornhorst, Julia A1 - Schwerdtle, Tanja A1 - Aschner, Michael A. A1 - McLean, John A. A1 - Bowman, Aaron B. T1 - Untargeted metabolic profiling identifies interactions between JF - Metallomics : integrated biometal science Y1 - 2015 U6 - https://doi.org/10.1039/c4mt00223g SN - 1756-5901 SN - 1756-591X VL - 7 IS - 2 SP - 363 EP - 370 PB - Royal Society of Chemistry CY - Cambridge ER - TY - JOUR A1 - Kumar, Kevin K. A1 - Goodwin, Cody R. A1 - Uhouse, Michael A. A1 - Bornhorst, Julia A1 - Schwerdtle, Tanja A1 - Aschner, Michael A. A1 - McLean, John A. A1 - Bowman, Aaron B. T1 - Untargeted metabolic profiling identifies interactions between Huntington's disease and neuronal manganese status JF - Metallomics N2 - Manganese (Mn) is an essential micronutrient for development and function of the nervous system. Deficiencies in Mn transport have been implicated in the pathogenesis of Huntington's disease (HD), an autosomal dominant neurodegenerative disorder characterized by loss of medium spiny neurons of the striatum. Brain Mn levels are highest in striatum and other basal ganglia structures, the most sensitive brain regions to Mn neurotoxicity. Mouse models of HD exhibit decreased striatal Mn accumulation and HD striatal neuron models are resistant to Mn cytotoxicity. We hypothesized that the observed modulation of Mn cellular transport is associated with compensatory metabolic responses to HD pathology. Here we use an untargeted metabolomics approach by performing ultraperformance liquid chromatography-ion mobility-mass spectrometry (UPLC-IM-MS) on control and HD immortalized mouse striatal neurons to identify metabolic disruptions under three Mn exposure conditions, low (vehicle), moderate (non-cytotoxic) and high (cytotoxic). Our analysis revealed lower metabolite levels of pantothenic acid, and glutathione (GSH) in HD striatal cells relative to control cells. HD striatal cells also exhibited lower abundance and impaired induction of isobutyryl carnitine in response to increasing Mn exposure. In addition, we observed induction of metabolites in the pentose shunt pathway in HD striatal cells after high Mn exposure. These findings provide metabolic evidence of an interaction between the HD genotype and biologically relevant levels of Mn in a striatal cell model with known HD by Mn exposure interactions. The metabolic phenotypes detected support existing hypotheses that changes in energetic processes underlie the pathobiology of both HD and Mn neurotoxicity. KW - hallervorden-spatz-syndrome KW - mobility-mass spectrometry KW - energy-metabolism KW - coenzyme-a KW - model KW - neurotoxicity KW - glutathione KW - database KW - cells KW - neurodegeneration Y1 - 2015 U6 - https://doi.org/10.1039/C4MT00223G SN - 1756-591X SN - 1756-5901 VL - 7 SP - 363 EP - 370 PB - RSC Publ. CY - Cambridge ER -